AI Article Synopsis

  • This study investigates the relationship between multiparametric MRI (mpMRI) parameters and the up-staging of pT3a prostate cancer in a large cohort of patients who underwent robotic-assisted radical prostatectomy (RARP).
  • The analysis included 383 cases, examining factors like age, BMI, PSA levels, and various MRI and histopathological parameters to determine their association with cancer progression.
  • Key findings reveal that higher PSA levels, PI-RADS scores, and ISUP grades are significantly linked to upstaging, while greater tumour coverage is correlated with worse surgical outcomes, indicating potential markers for cancer prognosis.

Article Abstract

Introduction: Multiparametric MRI (mpMRI) parameters of pT3a prostate cancer have not been examined in large cohort studies. Therefore, we aimed to identify factors associated with up-staging of mpMRI cT3a in post-operative histopathological confirmation.

Methods: Retrospective analysis of a prospectively maintained database of a single UK cancer centre. Only cT3a cases who underwent robotic-assisted radical prostatectomy (RARP) were included (N = 383). MRI and specimen histopathology was reviewed independently by expert uro-radiologists and uro-histopathologists, respectively. Factors included age, BMI, prostate-specific antigen (PSA) level, biopsy international society of urological pathology (ISUP) grade, Prostate Imaging Reporting & Data System (PI-RADS) score, tumour size, tumour coverage of gland (%), gland weight and surgical margins were analysed as predictors of pT3a prostate cancer.

Results: N = 383. Mean age 66 years (58-71), mean BMI 27.1 kg/m (25.0-30.0). 314 (82.0%) cases down- unchanged or down-staged, and 69 (18.0%) cases upstaged. PSA level (P = 0.002), PI-RADS score (P < 0.001) and ISUP grade (P < 0.001) are positively associated with upstage categories. ISUP grade ≥3 (OR 5.45, CI 1.88, 9.29, P < 0.002), PI-RADS score ≥4 (OR 3.92, CI 1.88-9.29, P < 0.001) and tumour coverage (OR 1.06, CI 1.05-1.08, P < 0.001) significantly positively associated with upstaging disease, with concurrent decreased probability of downstaging (OR 0.55, 0.14, 0.44, respectively, P < 0.05). Tumour coverage was positively correlated with increasing positive surgical margins (P < 0.05). Capsular contact > 15 mm was very unlikely to be upstaged (OR 0.36, CI 0.21-0.62, P < 0.001), aligning with published results past the widely accepted significant level for extracapsular disease on MRI.

Conclusion: The study has identified PSA level, ISUP, PI-RADS score, tumour volume and percentage coverage are key predictive factors in cT3a upstaging. This study uniquely shows tumour coverage percentage as a predictor of cT3a upstaging on mpMRI. ISUP is the strongest predictor, followed by PI-RADS score and tumour coverage of gland. Multi-institutional studies are needed to confirm our findings.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-024-05159-yDOI Listing

Publication Analysis

Top Keywords

factors associated
8
prostate cancer
8
pt3a prostate
8
psa level
8
pi-rads score
8
associated pathological
4
pathological up-staging
4
up-staging mri
4
mri ct3a
4
prostate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!